COURSERA ($COUR) posted quarterly earnings results on Thursday, July 24th. The company reported earnings of $0.12 per share, beating estimates of $0.09 by $0.03. The company also reported revenue of $187,100,000, beating estimates of $184,164,570 by $2,935,430.
You can see Quiver Quantitative's $COUR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
COURSERA Insider Trading Activity
COURSERA insiders have traded $COUR stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $COUR stock by insiders over the last 6 months:
- ANDREW Y. NG has made 0 purchases and 2 sales selling 25,110 shares for an estimated $207,519.
- ALAN B CARDENAS (SVP, General Counsel) has made 0 purchases and 2 sales selling 11,714 shares for an estimated $99,116.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
COURSERA Hedge Fund Activity
We have seen 126 institutional investors add shares of COURSERA stock to their portfolio, and 96 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 1,986,432 shares (+267.7%) to their portfolio in Q1 2025, for an estimated $13,229,637
- GILDER GAGNON HOWE & CO LLC removed 1,746,947 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $11,634,667
- MORGAN STANLEY added 1,559,242 shares (+16.0%) to their portfolio in Q1 2025, for an estimated $10,384,551
- GOLDMAN SACHS GROUP INC removed 1,535,331 shares (-51.8%) from their portfolio in Q1 2025, for an estimated $10,225,304
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,325,495 shares (-79.7%) from their portfolio in Q1 2025, for an estimated $8,827,796
- SENVEST MANAGEMENT, LLC removed 1,214,798 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $8,090,554
- BAILLIE GIFFORD & CO removed 911,288 shares (-10.3%) from their portfolio in Q1 2025, for an estimated $6,069,178
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
COURSERA Government Contracts
We have seen $3,281,017 of award payments to $COUR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- COURSERA ENTERPRISE LICENSES: $2,100,000
- COURSERA USER LICENSES FOR DFAS IN SUPPORT OF DIGITAL UNIVERSITY: $420,420
- COURSERA PLATFORM TRAINING LICENSES: $402,620
- COURSERA DFAS USER LICENSES IN SUPPORT OF DIGITAL UNIVERSITY: $207,753
- COURSERA LICENSE: $38,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
COURSERA Analyst Ratings
Wall Street analysts have issued reports on $COUR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Telsey Advisory Group issued a "Outperform" rating on 07/21/2025
- Needham issued a "Buy" rating on 07/21/2025
- B of A Securities issued a "Underperform" rating on 03/27/2025
- RBC Capital issued a "Outperform" rating on 01/31/2025
To track analyst ratings and price targets for COURSERA, check out Quiver Quantitative's $COUR forecast page.
COURSERA Price Targets
Multiple analysts have issued price targets for $COUR recently. We have seen 7 analysts offer price targets for $COUR in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Ryan MacDonald from Needham set a target price of $11.0 on 07/21/2025
- Sarang Vora from Telsey Advisory Group set a target price of $12.0 on 07/21/2025
- Bryan Smilek from JP Morgan set a target price of $9.0 on 07/16/2025
- Josh Baer from Morgan Stanley set a target price of $11.0 on 06/05/2025
- Nafeesa Gupta from B of A Securities set a target price of $7.0 on 03/27/2025
- Jennifer Swanson Lowe from UBS set a target price of $8.5 on 01/31/2025
- Rishi Jaluria from RBC Capital set a target price of $10.0 on 01/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
